Literature DB >> 19343134

The role of radiation therapy in pancreas cancer.

Lisa Hazard1.   

Abstract

The role of radiation therapy in pancreatic cancer continues to be investigated. Its use in the adjuvant setting remains controversial. Its use is more generally accepted in borderline resectable disease, but prospective data are sparse. Randomized trials have yielded conflicting data in locally advanced disease. Radiation techniques have improved over time, such that findings in older trials are not necessarily applicable in modern practice. This article reviews the role of radiation in resectable, borderline resectable, and unresectable pancreatic cancer.

Entities:  

Year:  2009        PMID： 19343134      PMCID： PMC2661119     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


  49 in total

Review 1.  Improvement of pancreatic cancer treatment from the Japanese experience in the 1980s.

Authors:  H Ozaki
Journal:  Int J Pancreatol       Date:  1992-08

2.  Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1987-06-15       Impact factor: 6.860

3.  Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.

Authors:  Ralf Wilkowski; Martin Thoma; Rolf Schauer; Andreas Wagner; Volker Heinemann
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

4.  Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Authors:  M H Kalser; S S Ellenberg
Journal:  Arch Surg       Date:  1985-08

5.  Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

Authors:  D J Klaassen; J M MacIntyre; G E Catton; P F Engstrom; C G Moertel
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

6.  Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.

Authors:  Michael T Milano; Steven J Chmura; Michael C Garofalo; Carla Rash; John C Roeske; Phillip P Connell; Oh-Hoon Kwon; Ashesh B Jani; Ruth Heimann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

7.  Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

Authors:  Douglas B Evans; Gauri R Varadhachary; Christopher H Crane; Charlotte C Sun; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Huamin Wang; Karen R Cleary; Gregg A Staerkel; Chusilp Charnsangavej; Elizabeth A Lano; Linus Ho; Renato Lenzi; James L Abbruzzese; Robert A Wolff
Journal:  J Clin Oncol       Date:  2008-07-20       Impact factor: 44.544

8.  Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx.

Authors:  J Overgaard; M Hjelm-Hansen; L V Johansen; A P Andersen
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

9.  Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer.

Authors:  Valerie Magnin; Vincent Moutardier; Marie Helene Giovannini; Bernard Lelong; Marc Giovannini; Frederic Viret; Genevieve Monges; Valerie Jeanne Bardou; Claude Alzieu; Jean Robert Delpero
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-04-01       Impact factor: 7.038

10.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089
View more
  23 in total

Review 1.  Advances in biomarker research for pancreatic cancer.

Authors:  Kruttika Bhat; Fengfei Wang; Qingyong Ma; Qinyu Li; Sanku Mallik; Tze-Chen Hsieh; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Monitoring the effects of anti-angiogenesis on the radiation sensitivity of pancreatic cancer xenografts using dynamic contrast-enhanced computed tomography.

Authors:  Ning Cao; Minsong Cao; Helen Chin-Sinex; Marc Mendonca; Song-Chu Ko; Keith M Stantz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

Review 3.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

4.  Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.

Authors:  David L Schwartz; James A Bankson; Robert Lemos; Stephen Y Lai; Arun K Thittai; Yi He; Galen Hostetter; Michael J Demeure; Daniel D Von Hoff; Garth Powis
Journal:  Mol Cancer Ther       Date:  2010-06-29       Impact factor: 6.261

Review 5.  Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.

Authors:  Patricia Dauer; Alice Nomura; Ashok Saluja; Sulagna Banerjee
Journal:  Pancreatology       Date:  2016-12-23       Impact factor: 3.996

Review 6.  Novel strategies for managing pancreatic cancer.

Authors:  Welley S Loc; Jill P Smith; Gail Matters; Mark Kester; James H Adair
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 7.  Adjuvant and neoadjuvant treatment in pancreatic cancer.

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

8.  Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis.

Authors:  Debasish Mohapatra; Biswajit Das; Voddu Suresh; Deepti Parida; Aliva Prity Minz; Usharani Nayak; Amlan Priyadarshee Mohapatra; Rajeeb K Swain; Shantibhusan Senapati
Journal:  Lab Invest       Date:  2021-11-12       Impact factor: 5.662

9.  Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

Authors:  Wenjie Sun; Cheng N Leong; Zhen Zhang; Jiade J Lu
Journal:  Radiat Oncol       Date:  2010-04-15       Impact factor: 3.481

10.  Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice.

Authors:  Lena Seifert; Gregor Werba; Shaun Tiwari; Nancy Ngoc Giao Ly; Susanna Nguy; Sara Alothman; Dalia Alqunaibit; Antonina Avanzi; Donnele Daley; Rocky Barilla; Daniel Tippens; Alejandro Torres-Hernandez; Mautin Hundeyin; Vishnu R Mani; Cristina Hajdu; Ilenia Pellicciotta; Philmo Oh; Kevin Du; George Miller
Journal:  Gastroenterology       Date:  2016-03-03       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.